These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11421876)

  • 21. [Retreatment of Helicobacter pylori infection with triple therapy after initial treatment failure].
    Kim N; Lim SH; Lee KH; Koo MS; Kim JM; Hwang JH; Kim JW; Lee DH; Jung HC; Song IS
    Korean J Gastroenterol; 2003 Sep; 42(3):195-203. PubMed ID: 14532741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Becker T; Börsch G
    Aliment Pharmacol Ther; 1996 Apr; 10(2):207-10. PubMed ID: 8730252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.
    Agro K; Blackhouse G; Goeree R; Willan AR; Huang JQ; Hunt RH; O'Brien BJ
    Pharmacoeconomics; 2001; 19(8):831-43. PubMed ID: 11596835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
    Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
    You JH; Lau W; Lee IY; Yung M; Ching JY; Chan FK; Lee KK
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):149-53. PubMed ID: 16625983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].
    Samsonov AA; Grechushnikov VB; Andreev DN; Iurenev GL; Korovina TI; Lezhneva IuA; Maev IV
    Ter Arkh; 2014; 86(8):56-61. PubMed ID: 25306745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
    Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
    Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer.
    Mao HV; Lak BV; Long T; Chung NQ; Thang DM; Hop TV; Chien NN; Hoan PQ; Henley KS; Perez-Perez GI; Connor BA; Stone CD; Chey WD
    Aliment Pharmacol Ther; 2000 Jan; 14(1):97-101. PubMed ID: 10632652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
    Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S
    Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
    Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
    Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
    Sotudehmanesh R; Malekzadeh R; Fazel A; Massarrat S; Ziad-Alizadeh B; Eshraghian MR
    J Gastroenterol Hepatol; 2001 Mar; 16(3):264-8. PubMed ID: 11339416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
    Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
    Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
    Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.